View in EDS

Phase II Study of Sunitinib in Tumors With c-KIT Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol V.

Saved in:
Bibliographic Details
Title: Phase II Study of Sunitinib in Tumors With c-KIT Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol V.
Authors: Gien, Lilian T.1 (AUTHOR) lilian.gien@sunnybrook.ca, Song, Zihe2 (AUTHOR), Poklepovic, Andrew3 (AUTHOR), Collisson, Eric A.4 (AUTHOR), Zwiebel, James A.5 (AUTHOR), Gray, Robert J.2 (AUTHOR), Wang, Victoria2 (AUTHOR), McShane, Lisa M.6 (AUTHOR), Rubinstein, Larry V.6 (AUTHOR), Patton, David R.7 (AUTHOR), Williams, P. Mickey8,9 (AUTHOR), Hamilton, Stanley R.10 (AUTHOR), Tricoli, James V.11 (AUTHOR), Conley, Barbara A.11 (AUTHOR), Arteaga, Carlos L.12 (AUTHOR), Harris, Lyndsay N.11 (AUTHOR), O'Dwyer, Peter J.13 (AUTHOR), Chen, Alice P.14 (AUTHOR), Flaherty, Keith T.15 (AUTHOR)
Source: JCO Precision Oncology. 12/12/2024, Vol. 8, p1-9. 9p.
Database: Academic Search Ultimate
Description
ISSN:24734284
DOI:10.1200/PO-24-00514